| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | -3.8% | -14.6% |
| R&D Expense | $175K | +4.7% | +10.5% |
| SG&A Expense | $7.2M | +19.2% | +448.5% |
| Operating Income | -$7.3M | -20.4% | -521.3% |
| Interest Expense | $97K | +44.8% | +310.6% |
| Pre-tax Income | -$5.4M | -11.7% | -23.8% |
| Income Tax | -$333K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.4M | -33.1% | +40.5% |
| Short-term Investments | $2.2M | -28.3% | -96.8% |
| Accounts Receivable | $264K | -5.7% | -11.2% |
| Current Assets | $83.1M | -5.1% | -19.2% |
| Total Assets | $106.8M | -1.7% | -17.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | — |
| Capital Expenditures | $109K | — | — |
| Investing Cash Flow | -$41.0M | — | — |
| Financing Cash Flow | $854K | — | — |
| Free Cash Flow | -$3.8M | — | — |
| — |
| +0.0% |
| Net Income | -$5.4M | -11.4% | -33.1% |
| EPS (Basic) | -$0.14 | -16.7% | -27.3% |
| EPS (Diluted) | -$0.14 | -16.7% | -27.3% |
| $46.4M |
| +8.9% |
| +16.0% |
| Total Liabilities | $49.9M | +7.2% | +10.2% |
| Stockholders' Equity | $52.4M | -9.0% | -29.2% |